Cite Filings / XFOR / 0000315066-26-002326

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

X4 Pharmaceuticals, Inc Filed 2026-10-07 Acc 0000315066-26-002326

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-13 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-10-08 8-K Material agreement · Agreement ended · New debt or obligation · Unregistered share sale · Regulation FD disclosure
2026-10-07 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-10-05 4 Chief Financial Officer sold 11,767 shares at $2.86 ($33,658)
2026-10-01 144 Sale of Securities
2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…